Literature DB >> 11899178

Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy.

Thomas Menzel1, Thorsten Kramm, Stephan Wagner, Susanne Mohr-Kahaly, Eckhard Mayer, Juergen Meyer.   

Abstract

BACKGROUND: For patients with chronic thromboembolic pulmonary hypertension who undergo pulmonary thromboendarterectomy (PTE) it has not yet been systematically investigated how operation affects the severity of tricuspid regurgitation (TR). This study sought (1) to evaluate the extent of TR reversibility after operation, (2) to identify potential predictors of the reversibility of TR, and (3) to investigate the influence of geometric and hemodynamic alterations on the extent of TR severity.
METHODS: Thirty-nine patients (55+/-12 years) undergoing PTE without tricuspid valve repair were investigated before and 13+/-8 days after operation by Doppler color flow mapping. Geometry of the tricuspid valve as well as right ventricular size and function were determined with echocardiography. Mean pulmonary arterial pressure was determined invasively.
RESULTS: After PTE, mean pulmonary arterial pressure was significantly lower (48+/-10 versus 25+/-7 mm Hg, p < 0.05). Most of the patients had a distinct reduction of TR, and the improvement trend showed on the severity scale: number of patients with 4+TR (23 --> 4), 3+TR (12 --> 12), 2+TR (2 --> 13), and 1+TR (2 --> 10). Examination after PTE revealed profound reduction of right ventricular size and annulus diameter, with a normalization of the valvular geometry. However, none of the study variables were useful as indicators of the postoperative outcome.
CONCLUSIONS: After PTE without additional valve repair most patients show significantly reduced severity of TR soon afterward; the very few cases in which TR does not improve remain unidentifiable before operation. Our recommendation is consequently to refrain from additional tricuspid repair in patients undergoing PTE.

Entities:  

Mesh:

Year:  2002        PMID: 11899178     DOI: 10.1016/s0003-4975(01)03573-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

Review 1.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 2.  Tricuspid valve repair for treatment and prevention of secondary tricuspid regurgitation in patients undergoing mitral valve surgery.

Authors:  Ani C Anyanwu; Joanna Chikwe; David H Adams
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

3.  Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Authors:  Sanjay Mehta; Doug Helmersen; Steeve Provencher; Naushad Hirani; Fraser D Rubens; Marc De Perrot; Mark Blostein; Kim Boutet; George Chandy; Carole Dennie; John Granton; Paul Hernandez; Andrew M Hirsch; Karen Laframboise; Robert D Levy; Dale Lien; Simon Martel; Gerard Shoemaker; John Swiston; Justin Weinkauf
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

Review 4.  Recent advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension including Japanese experiences.

Authors:  Hitoshi Ogino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-09-26

5.  Right ventricular reverse remodeling after pulmonary endarterectomy: magnetic resonance imaging and clinical and right heart catheterization assessment.

Authors:  Marius Berman; Deepa Gopalan; Linda Sharples; Nick Screaton; Caroline Maccan; Karen Sheares; Joanna Pepke-Zaba; John Dunning; Steven Tsui; David P Jenkins
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

6.  Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography.

Authors:  Justin D Roberts; Paul R Forfia
Journal:  Pulm Circ       Date:  2011 Apr-Jun       Impact factor: 3.017

7.  Impact of pulmonary thromboendarterectomy on tricuspid regurgitation in patients with chronic thromboembolic pulmonary hypertension: a single-center prospective cohort experience.

Authors:  Yanan Zhen; Jianbin Zhang; Xiaopeng Liu; Guang Sun; Xia Zheng; Yongxin Han; Zhenguo Zhai; Aili Li; Fan Lin; Peng Liu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

8.  Reverse remodeling of tricuspid valve morphology and function in chronic thromboembolic pulmonary hypertension patients following pulmonary thromboendarterectomy: a cardiac magnetic resonance imaging and invasive hemodynamic study.

Authors:  Christian Alcaraz Frederiksen; Farhad Waziri; Steffen Ringgaard; Søren Mellemkjær; Tor Skibsted Clemmensen; Vibeke Elisabeth Hjortdal; Sten Lyager Nielsen; Steen Hvitfeldt Poulsen
Journal:  BMC Cardiovasc Disord       Date:  2021-09-17       Impact factor: 2.298

9.  Right ventricular plasticity and functional imaging.

Authors:  Evan L Brittain; Anna R Hemnes; Mary Keebler; Mark Lawson; Benjamin F Byrd; Tom Disalvo
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

10.  Clinical outcomes of thromboendarterectomy for chronic thromboembolic pulmonary hypertension: 12-year experience.

Authors:  Se Jin Oh; Jin San Bok; Ho Young Hwang; Kyung-Hwan Kim; Ki Bong Kim; Hyuk Ahn
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-02-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.